Parkinsons Disease

Papers
(The median citation count of Parkinsons Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment37
Update on the Management of Parkinson’s Disease for General Neurologists25
Evaluation of Wearable Sensor Devices in Parkinson’s Disease: A Review of Current Status and Future Prospects25
Proactive and Integrated Management and Empowerment in Parkinson’s Disease: Designing a New Model of Care23
Social Symptoms of Parkinson’s Disease22
Exercise Therapies for Parkinson’s Disease: A Systematic Review and Meta-Analysis20
Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease19
Effect of Exercise on Quality of Life in Parkinson’s Disease: A Systematic Review and Meta-Analysis14
5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson’s Treatment14
Freezing of Gait in Parkinson’s Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms13
Role of Long Noncoding RNAs in Parkinson’s Disease: Putative Biomarkers and Therapeutic Targets13
Self-Management Education for Persons with Parkinson’s Disease and Their Care Partners: A Quasi-Experimental Case-Control Study in Clinical Practice13
Action Imagery and Observation in Neurorehabilitation for Parkinson’s Disease (ACTION-PD): Development of a User-Informed Home Training Intervention to Improve Functional Hand Movements11
Self-Management Components as Experienced by People with Parkinson’s Disease and Their Carers: A Systematic Review and Synthesis of the Qualitative Literature11
Low-Frequency Repetitive Transcranial Magnetic Stimulation over Right Dorsolateral Prefrontal Cortex in Parkinson’s Disease10
Perspectives on Care for Late-Stage Parkinson’s Disease10
Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease10
Association of p53 with Neurodegeneration in Parkinson’s Disease10
Feasibility Aspects of Exploring Exercise-Induced Neuroplasticity in Parkinson’s Disease: A Pilot Randomized Controlled Trial9
Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study9
Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography9
Movement Disorders Associated with COVID-199
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics9
Wearable Sensors Measure Ankle Joint Changes of Patients with Parkinson’s Disease before and after Acute Levodopa Challenge8
Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson’s Disease and Other Movement Disorders: A Meta-Analysis8
Enhancement of Executive Functions but Not Memory by Multidomain Group Cognitive Training in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Multicenter Randomized Controlled Trial8
Parkinson’s Disease-Related Risk of Suicide and Effect of Deep Brain Stimulation: Meta-Analysis7
Association of Tooth Loss with New-Onset Parkinson’s Disease: A Nationwide Population-Based Cohort Study7
Abnormal Gray Matter Volume and Functional Connectivity in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder7
Parkinsonics: A Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms in Idiopathic Parkinson Disease6
Motor/Nonmotor Symptoms and Progression in Patients with Parkinson’s Disease: Prevalence and Risks in a Longitudinal Study6
Ultrasonography of the Vagus Nerve in the Diagnosis of Parkinson’s Disease6
Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study6
Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease6
Dance Is an Accessible Physical Activity for People with Parkinson’s Disease6
The Origin of Abnormal Beta Oscillations in the Parkinsonian Corticobasal Ganglia Circuits6
Social Cognition in Patients with Early-Onset Parkinson’s Disease6
Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson’s Disease6
Use of a Smartphone to Gather Parkinson’s Disease Neurological Vital Signs during the COVID-19 Pandemic5
Taking Time: A Mixed Methods Study of Parkinson’s Disease Caregiver Participation in Activities in Relation to Their Wellbeing5
Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis5
The Relationship between Side of Onset and Cerebral Regional Homogeneity in Parkinson’s Disease: A Resting-State fMRI Study5
Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life5
Crocetin Alleviates Inflammation in MPTP-Induced Parkinson’s Disease Models through Improving Mitochondrial Functions5
“Does the Response to Morning Medication Predict the ADL-Level of the Day in Parkinson’s Disease?”5
Risk of Dementia in Patients with Depression or Parkinson’s Disease: A Retrospective Cohort Study5
Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson’s Disease5
Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the Gastrointestinal Tract Is a Sensitive Predictor for Parkinson’s Disease5
Delirium after Deep Brain Stimulation in Parkinson’s Disease5
Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines5
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality5
Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice5
Quantitative Analysis of Postural Instability in Patients with Parkinson’s Disease4
DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model4
Predicting Cognitive Decline in Parkinson’s Disease with Mild Cognitive Impairment: A One-Year Observational Study4
Evaluation of Patients with Parkinson’s Disease in Intensive Care Units: A Cohort Study4
Autonomic Dysfunctions in Parkinson’s Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment4
The Beneficial Effects of Conventional Visual Cues Are Retained When Augmented Reality Glasses Are Worn4
Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson’s Disease4
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis4
Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson’s Disease Subtype4
Prediction of Life Satisfaction in People with Parkinson’s Disease4
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search4
α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson’s Disease4
Off Time Independently Affects Quality of Life in Advanced Parkinson’s Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson’s3
Telerehabilitation: A Practical Remote Alternative for Coaching and Monitoring Physical Kinetic Therapy in Patients with Mild and Moderate Disabling Parkinson’s Disease during the COVID-19 Pandemic3
Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson’s Disease3
Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo3
Prevalence of Fabry Disease among Patients with Parkinson’s Disease3
Delivering Optimal Care to People with Cognitive Impairment in Parkinson’s Disease: A Qualitative Study of Patient, Caregiver, and Professional Perspectives3
Pareidolia in Parkinson’s Disease and Multiple System Atrophy3
The Efficacy of a Newly Developed Cueing Device for Gait Mobility in Parkinson’s Disease3
Onset of Postural Instability in Parkinson’s Disease Depends on Age rather than Disease Duration3
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson’s Disease in Rats3
Invalid Self-Assessment of Olfactory Functioning in Parkinson’s Disease Patients May Mislead the Neurologist3
Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage3
Intraoperative Quantitative Measurements for Bradykinesia Evaluation during Deep Brain Stimulation Surgery Using Leap Motion Controller: A Pilot Study3
Combining a Cognitive Concurrent Task with a Motor or Motor-Cognitive Task: Which Is Better to Differentiate Levels of Affectation in Parkinson’s Disease?3
Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease3
Cognitive Impairment in Genetic Parkinson’s Disease3
Ultrasonographic Changes in Brain Hemodynamics in Patients with Parkinson’s Disease and Risk Factors for Cerebrovascular Disease: A Pilot Study3
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models3
Nonmotor-Related Quality of Life in Parkinson’s Patients with Subjective Memory Complaints: Comparison with PDQ-393
Validation of the German Version of the New Freezing of Gait Questionnaire for People with Parkinson‘s Disease3
Two-Channel Portable Biopotential Recording System Can Detect REM Sleep Behavioral Disorder: Validation Study with a Comparison of Polysomnography2
Development and Initial Validation of the Chinese Version of the Florida Surgical Questionnaire for Parkinson’s Disease2
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors2
Psychosocial Adjustment of In-Home Caregivers of Family Members with Dementia and Parkinson’s Disease: A Comparative Study2
Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson’s Disease: A Pilot Study2
Effects of Vestibular Rehabilitation on Fatigue and Activities of Daily Living in People with Parkinson’s Disease: A Pilot Randomized Controlled Trial Study2
Validation of the Parkinson’s Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy2
Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson’s Disease2
Validation of Parkinson’s Disease-Related Questionnaires in South Africa2
Evidence of Rehabilitative Impact of Progressive Resistance Training (PRT) Programs in Parkinson Disease: An Umbrella Review2
Short-Term Motor Outcomes in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study2
The Relationship between Visual-Evoked Potential and Optic Coherence Tomography and Clinical Findings in Parkinson Patients2
Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease2
Event-Related Potentials Elicited by Face and Face Pareidolia in Parkinson’s Disease2
Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies2
Evaluation of Motor Complications in Parkinson’s Disease: Understanding the Perception Gap between Patients and Physicians2
Management, Levels of Support, Quality of Life, and Social Inclusion in Parkinson’s Disease: Interventions, Innovation, and Practice Development2
Differences in Home Health Nursing Care for Patients with Parkinson’s Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V2
GuitarPD: A Randomized Pilot Study on the Impact of Nontraditional Guitar Instruction on Functional Movement and Well-Being in Parkinson’s Disease2
Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS)2
0.01937198638916